CYP3A4 activity of paclitaxel and vinorelbine in microemulsions.

被引：0
|
作者：
Tiitto, Ville [1 ]
Chang, Youngil [1 ]
Nornoo, Adwoa [1 ]
机构：
[1] Palm Beach Atlantic Univ, W Palm Beach, FL USA
来源：
PHARMACOTHERAPY | 2012年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
430
引用
收藏
页码：E303 / E303
页数：1
相关论文
共 50 条
  • [21] Lacosamide Has No Effect on the Enzymatic Activity of CYP3A4
    Cawello, Willi
    Surmann, Erwin
    Waitzinger, Josef
    NEUROLOGY, 2012, 78
  • [22] Bufalin inhibits CYP3A4 activity in vitro and in vivo
    Li, Hai-yun
    Xu, Wen
    Zhang, Xi
    Zhang, Wei-dong
    Hu, Li-wei
    ACTA PHARMACOLOGICA SINICA, 2009, 30 (05) : 646 - 652
  • [23] CYP3A4 intron 6 C>T SNP (CYP3A4*22) encodes lower CYP3A4 activity in cancer patients, as measured with probes midazolam and erythromycin
    Elens, Laure
    Nieuweboer, Annemieke
    Clarke, Stephen J.
    Charles, Kellie A.
    de Graan, Anne-Joy
    Haufroid, Vincent
    Mathijssen, Ron H. J.
    van Schaik, Ron H. N.
    PHARMACOGENOMICS, 2013, 14 (02) : 137 - 149
  • [24] Effect of hemodialysis on hepatic CYP3A4 activity.
    Nolin, TD
    Appiah, K
    Kendrick, SA
    Le, P
    McMonagle, E
    Himmelfarb, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P23 - P23
  • [25] Resveratrol modulates the catalytic activity of human CYP3A4 and CYP3A5.
    Chang, TKH
    Yeung, KYR
    FASEB JOURNAL, 2000, 14 (08): : A1336 - A1336
  • [26] Fentanyl Enhances Hepatotoxicity of Paclitaxel via Inhibition of CYP3A4 and ABCB1 Transport Activity in Mice
    Xie, Jing-Dun
    Huang, Yang
    Chen, Dong-Tai
    Pan, Jia-Hao
    Bi, Bing-Tian
    Feng, Kun-Yao
    Huang, Wan
    Zeng, Wei-An
    PLOS ONE, 2015, 10 (12):
  • [27] Role of CYP3A4 in human hepatic diltiazem N-demethylation: Inhibition of CYP3A4 activity by oxidized diltiazem metabolites
    Sutton, D
    Butler, AM
    Nadin, L
    Murray, M
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 282 (01): : 294 - 300
  • [28] CYP3A4 is mainly responsibile for the metabolism of a new vinca alkaloid, vinorelbine, in human liver microsomes
    Kajita, J
    Kuwabara, T
    Kobayashi, H
    Kobayashi, S
    DRUG METABOLISM AND DISPOSITION, 2000, 28 (09) : 1121 - 1127
  • [29] Effect of Itraconazole, a CYP3A4 Inhibitor, and Rifampin, a CYP3A4 Inducer, on the Pharmacokinetics of Vatiquinone
    Lee, Lucy
    Thoolen, Martin
    Ma, Jiyuan
    Kaushik, Diksha
    Golden, Lee
    Kong, Ronald
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (12): : 1283 - 1290
  • [30] 4β-hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans
    Diczfalusy, Ulf
    Nylen, Hanna
    Elander, Pontus
    Bertilsson, Leif
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (02) : 183 - 189
12345